Analysis of human bulk and single-cell RNA-seq datasets demonstrated that an inflammatory monocyte signature derived from our data was associated with improved patient outcomes and response to immune checkpoint inhibitors.<h4>Conclusions</h4>These data demonstrate that CD8<sup>+</sup> T cells contribute to tumor control even in the absence of direct antigen presentation by tumor cells. This evidence concerns the gene CD8A and neoplasm.